0.00
-99.00%
Close of 2 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bionovate Technologies
Its shares trade under the ticker BIIO. It has been listed since 28 March 2014. In the fiscal year to 30 June 2017, it reported revenue of $5,386 and a net loss of $323,313. At that date it held shareholders' equity of −$229,148.
Bionovate Technologies Corp. engages in the acquisition and development of technologies based on protected and wholly-owned internet protocol in the medical devices sector. The company is headquartered in Cham, Zug. The company went IPO on 2014-03-28. The firm is involved in the review of opportunities for merger and acquisition. The firm has no operations.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 28 Mar 2014
Leadership
Pay as last reported
- Mr. Timothy JonesPresident, Chief Executive Officer, Chief Financial Officer, Treasurer, Company Secretary, Director, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bionovate Technologies Corp has a strong research and development team, which enables them to stay innovative and ahead of industry trends. Their technological capabilities give them a competitive edge.
- The company has a well-established network of strategic partnerships and collaborations within the industry, allowing them to leverage shared resources and knowledge, which enhances their overall capabilities.
- Bionovate Technologies Corp has a solid financial position, supported by consistent revenue growth and positive cash flow. This stability enables them to invest in new projects and expand their operations.
Weaknesses
- One of the weaknesses of Bionovate Technologies Corp is their limited market presence and brand recognition. This makes it challenging for them to compete against more established players in the industry.
- The company heavily relies on a few key customers for a significant portion of their revenue. This concentration creates vulnerability and exposes them to risks if these key customers were to reduce or terminate their contracts.
- Bionovate Technologies Corp may face challenges in scaling their operations due to limited resources and infrastructure. This could hinder their ability to quickly adapt to market demands and seize opportunities.
Opportunities
- The increasing demand for advanced technologies and solutions in various industries provides a significant growth opportunity for Bionovate Technologies Corp. They can capitalize on this demand by further developing and commercializing their innovative products.
- Expanding their market reach geographically and entering new market segments could also open up new avenues for growth and diversification. Bionovate Technologies Corp can explore strategic partnerships or acquisitions to accelerate their expansion.
- Government initiatives and regulations supporting green and sustainable technologies create a favorable environment for Bionovate Technologies Corp to leverage their expertise and develop solutions in this space.
Threats
- The rapid pace of technological advancements poses a threat to Bionovate Technologies Corp. If they fail to keep up with emerging technologies or disrupt their industries, they risk losing market share and relevance.
- Intense competition from both established companies and new entrants can squeeze Bionovate Technologies Corp's market share and pricing power. They must continuously innovate and differentiate themselves to stay competitive.
- Economic uncertainties and market volatility can impact Bionovate Technologies Corp's financial performance and demand for their products. They need to maintain a robust financial strategy and flexibility to navigate such challenges.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.